CME WEBINAR BROADCAST | JUNE 28, 2019 | 8 PM EST
Verteporfin for photodynamic therapy (PDT) has been approved for decades as a treatment for retinal disorders. Eye care professionals need to understand all the real-world clinical scenarios in which the use of PDT alone or in combination with anti-VEGF therapy can be a more efficacious treatment option than anti-VEGF monotherapy.
Direct Link: EVOLVEMED
Is photodynamic therapy still useful? The image above is a case of a 49 year old with a peripapillary lesion and macular edema treated with a single application of PDT. From left to right is the result over 6 months.